UPDATED 20.02.2014 12:58

Organised cervical cancer screening programme in Finland in the invitation year 2004. Numbers and percentage distribution of primary screening test results, referrals for further investigations, and histological diagnosis of the cervix uteri. Information registered from 442 municipalities (out of 444).

Screening Screened Referral Histological diagnosis
test     Invasive
carcinoma
Microinvasive
carcinoma
Carcinoma
in situ
Dysplasia
gravis
Dysplasia
moderata
Dysplasia
levis
Other or
normal
  n n % n % n % n % n % n % n % n %
Pap test1 178872 1357 0.76 12 0.01 8 0.00 45 0.03 148 0.08 201 0.11 180 0.10 763 0.43
I 166048 - - - - - - - - - - - - - - - -
II 11500 132 0.07 1 0.00 - - 2 0.00 2 0.00 6 0.00 10 0.01 111 0.06
III 1083 1081 0.60 8 0.00 1 0.00 16 0.01 93 0.05 166 0.09 163 0.09 634 0.35
IV 138 138 0.08 3 0.00 6 0.00 26 0.01 53 0.03 29 0.02 7 0.00 14 0.01
V 7 6 0.00 - - 1 0.00 1 0.00 - - - - - - 4 0.00
Inadequate 96 - - - - - - - - - - - - - - - -
Unknown - - - - - - - - - - - - - - - - -
HPV test 14607 187 1.28 4 0.03 - - 1 0.01 13 0.09 48 0.33 32 0.22 89 0.61
Negative1 13453 8 0.05 - - - - 1 0.01 - - - - 1 0.01 6 0.04
Positive2 1154 179 1.23 4 0.03 - - - - 13 0.09 48 0.33 31 0.21 83 0.57
Total 193479 1544 0.80 16 0.01 8 0.00 46 0.02 161 0.08 249 0.13 212 0.11 852 0.44

1 Women with Papanicolaou class I or II or negative HPV test are not referred for further examinations unless repeated cytology or other results are suggestive of cancer.
2 Women whose HPV test is positive are referred for further examinations on the basis of cytology or a repeatedly positive result.